These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 6092611)

  • 1. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo.
    Snell LD; Mueller ZL; Gannon RL; Silverman PB; Johnson KM
    J Pharmacol Exp Ther; 1984 Nov; 231(2):261-9. PubMed ID: 6092611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior.
    Snell LD; Johnson KM
    J Pharmacol Exp Ther; 1985 Oct; 235(1):50-7. PubMed ID: 2864436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices.
    Vickroy TW; Johnson KM
    J Pharmacol Exp Ther; 1982 Dec; 223(3):669-74. PubMed ID: 6128403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.
    Koek W; Colpaert FC; Woods JH; Kamenka JM
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1019-27. PubMed ID: 2674416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
    Snell LD; Johnson KM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phencyclidine (PCP)-like drugs on turning behavior, 3H-dopamine uptake, and 3H-PCP binding.
    Johnson KM; Snell LD
    Pharmacol Biochem Behav; 1985 May; 22(5):731-5. PubMed ID: 2989942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution and antagonism in rats trained to discriminate (+)-N-allylnormetazocine from saline.
    Balster RL
    J Pharmacol Exp Ther; 1989 Jun; 249(3):749-56. PubMed ID: 2471825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptors and secretory actions of sigma/phencyclidine agonists in anterior pituitary cells.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Dec; 121(6):2044-54. PubMed ID: 2824179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phencyclidine: behavioral and biochemical evidence supporting a role for dopamine.
    Johnson KM
    Fed Proc; 1983 Jun; 42(9):2579-83. PubMed ID: 6133782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of carbachol-induced inositol phosphate accumulation by phencyclidine, phencyclidine-like ligands and sigma agonists involves blockade of the muscarinic cholinergic receptor: a novel dioxadrol-preferring interaction.
    Brog JS; Beinfeld MC
    J Pharmacol Exp Ther; 1990 Sep; 254(3):952-6. PubMed ID: 2203900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo binding of [3H]d-N-allylnormetazocine and [3H]haloperidol to sigma receptors in the mouse brain.
    Weissman AD; Broussolle EP; London ED
    J Chem Neuroanat; 1990; 3(5):347-54. PubMed ID: 2171560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
    Contreras PC; Johnson S; Freedman R; Hoffer B; Olsen K; Rafferty MF; Lessor RA; Rice KC; Jacobson AE; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1101-7. PubMed ID: 3018219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"sigma opiate" receptor commonality.
    Sircar R; Nichtenhauser R; Ieni JR; Zukin SR
    J Pharmacol Exp Ther; 1986 May; 237(2):681-8. PubMed ID: 3009795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of opioid, sigma, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20.
    Kushner L; Zukin SR; Zukin RS
    Mol Pharmacol; 1988 Nov; 34(5):689-94. PubMed ID: 2848188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantiomeric and diastereomeric dioxadrols: behavioral, biochemical and chemical determination of the configuration necessary for phencyclidine-like properties.
    Jacobson AE; Harrison EA; Mattson MV; Rafferty MF; Rice KC; Woods JH; Winger G; Solomon RE; Lessor RA; Silverton JV
    J Pharmacol Exp Ther; 1987 Oct; 243(1):110-7. PubMed ID: 2822892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phencyclidine selectively inhibits N-methyl-D-aspartate-induced hippocampal [3H]norepinephrine release.
    Jones SM; Snell LD; Johnson KM
    J Pharmacol Exp Ther; 1987 Feb; 240(2):492-7. PubMed ID: 2879908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat.
    Mattia A; Marquis KL; Leccese AP; el-Fakahany EE; Moreton JE
    J Pharmacol Exp Ther; 1988 Aug; 246(2):797-802. PubMed ID: 2841454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes.
    Bowyer JF; Spuhler KP; Weiner N
    J Pharmacol Exp Ther; 1984 Jun; 229(3):671-80. PubMed ID: 6726652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
    Largent BL; Gundlach AL; Snyder SH
    J Pharmacol Exp Ther; 1986 Aug; 238(2):739-48. PubMed ID: 3016248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of drugs that bind to PCP and sigma receptors on punished responding.
    McMillan DE; Hardwick WC; deCosta BR; Rice KC
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1015-8. PubMed ID: 1653832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.